Literature DB >> 30008031

Meta-analysis of laparoscopy sentinel lymph node mapping in endometrial cancer.

Lijun Wang1, Fang Liu2.   

Abstract

OBJECTIVE: Sentinel lymph node (SLN) mapping for endometrial cancer (EC) is a contemporary technique that could provide benefits over traditional lymphadenectomy. Comprehensive published literature on sentinel lymph node mapping for laparoscopy surgery in EC, data extraction, evidence-based medicine-based methods, and meta-analysis are carried out to further explore sentinel lymph node mapping in laparoscopy surgery in EC. The application value provides basis for prevention and treatment of EC.
MATERIALS AND METHODS: We searched Medline, Embase, and the Cochrane Central for studies published before February 1, 2018 which had a sample size of at least ten patients, and reported the detection rate and/or sensitivity of the laparoscopy SLN biopsy. Statistical analysis was conducted using R-2.15.2 software.
RESULTS: The overall detection rate of sentinel lymph node mapping was included in 389 patients of 8 studies, ranging from 25 to 71 patients, which was 96% (95% confidence interval 95-98). 366 patients were included in bilateral sentinel node detection rate, ranging from 30 to 71 patients; it was 73% (95% confidence interval, 69-77). The sensitivity of the overall detection rate of sentinel lymph node mapping was 96.3% with a sensitivity of 73.1% bilateral sentinel node detection rate.
CONCLUSIONS: Laparoscopy sentinel lymph node localization is feasible and accurately predicts lymph node status in patients with EC. For patients with early stage clinical disease, it is very important to screen patients with no lymph node metastasis, reduce the range of surgical resection, reduce the incidence of the corresponding complications, and improve the quality of patients.

Entities:  

Keywords:  Endometrial cancer; Laparoscopy; Sentinel lymph node

Mesh:

Year:  2018        PMID: 30008031     DOI: 10.1007/s00404-018-4845-y

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  4 in total

1.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

2.  A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?

Authors:  Lei Ye; ShuangDi Li; Wen Lu; QiZhi He; YiRan Li; BiLan Li; XiaoJun Wang; Qin Yan; XiaoPing Wan
Journal:  Oncologist       Date:  2019-07-03

3.  Cancer of the corpus uteri: 2021 update.

Authors:  Martin Koskas; Frédéric Amant; Mansoor Raza Mirza; Carien L Creutzberg
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

4.  The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer.

Authors:  Zhao Liu; Jinghe Lang; Ming Wu; Lei Li
Journal:  Front Oncol       Date:  2021-02-16       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.